Back to Search
Start Over
Entrectinib for the treatment of metastatic NSCLC: safety and efficacy
- Source :
- Expert review of anticancer therapy. 20(5)
- Publication Year :
- 2020
-
Abstract
- Introduction: Gene fusions are strong driver alterations in various cancers, increasingly diagnosed with multiple testing techniques. ROS1 fusions can be found in 1-2% of non-small cell lung cancer...
- Subjects :
- 0301 basic medicine
Oncology
medicine.medical_specialty
Indazoles
Lung Neoplasms
medicine.medical_treatment
Entrectinib
Targeted therapy
03 medical and health sciences
0302 clinical medicine
Internal medicine
Carcinoma, Non-Small-Cell Lung
Proto-Oncogene Proteins
medicine
ROS1
Animals
Humans
Pharmacology (medical)
Lung cancer
Protein Kinase Inhibitors
Gene Rearrangement
business.industry
Protein-Tyrosine Kinases
medicine.disease
030104 developmental biology
030220 oncology & carcinogenesis
Benzamides
Disease Progression
Non small cell
Gene Fusion
business
Subjects
Details
- ISSN :
- 17448328
- Volume :
- 20
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- Expert review of anticancer therapy
- Accession number :
- edsair.doi.dedup.....959610ea0a5c7006bf42b2d81490ff55